On October 7, 10x Genomics fell 6.72% in regular trading, trading at $74.18/share, with Turnover of $58.5 million. The decline came amid broad weakness across life sciences tools and services names.
The overall sector showed scattered moves, with Thermo Fisher Scientific up 0.13%, Tempus AI down 3.36%, Illumina down 2.25%, Danaher down 0.19%, and Charles River Laboratories down 2.02%. Technical platform stocks broadly faced selling pressure.
The company recently announced first commercial shipments of its Atera spatial biology platform and received a Buy rating with a $110 price target from Argus Research, but sector-level sentiment dominated the day's trading.
10x Genomics develops instruments, consumables, and software for single-cell and spatial analysis of biological systems across North America, Europe, the Middle East, Africa, China, and Asia Pacific, serving academic, government, biopharmaceutical, and biotechnology institutions.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)